Literature DB >> 8413786

Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables.

G Gamba1, J L Mejía, S Saldívar, J C Peña, R Correa-Rotter.   

Abstract

The characteristics, survival rate and risk factors associated with death in patients with end-stage renal failure treated with chronic ambulatory peritoneal dialysis (CAPD) were studied. This is a retrospective study of a cohort of 206 patients, from which the follow-up was complete in 190 patients (92%). Only 16 patients (8%) were lost. The study group is composed of 118 males and 88 females, with a mean age of 39 +/- 15 years. The origin of the renal disease was: unknown in 90 patients (44%); diabetes mellitus in 50 (24%); systemic lupus erythematosus in 16 (8%); obstructive uropathy in 15 (7%); glomerulonephritis in 14 (7%), and miscellaneous in 21 (10%). The average follow-up was 12 +/- 11 months. At the end of study, 66 patients were dead (32%). CAPD was discontinued in 12 (6%). Thirty-eight patients (18%) received kidney transplantation. The survival rate for the whole group was 67 and 48% at 1 and 3 years, respectively. Multivariate survival analysis according to the Cox proportional-hazard model showed that the most powerful predictor associated with high risk of death was low serum albumin levels. According to the Cox model other independent variables significantly associated with increase in the probability of death while on CAPD were advancing age, low serum creatinine concentrations and elevated serum cholesterol levels. These results indicate that the risk factors associated with death in CAPD patients are similar to those observed for hemodialysis patients and suggest that using simple laboratory measurements at the enrollment in CAPD the relative risk of death for each patient can be estimated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413786     DOI: 10.1159/000187435

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  Lipid lowering in renal disease.

Authors:  Alice Kennard; Richard Singer
Journal:  Aust Prescr       Date:  2017-08-01

2.  Baseline Predictors of Mortality among Predominantly Rural-Dwelling End-Stage Renal Disease Patients on Chronic Dialysis Therapies in Limpopo, South Africa.

Authors:  Ramon A Tamayo Isla; Oluwatoyin I Ameh; Darlington Mapiye; Charles R Swanepoel; Aminu K Bello; Andrew R Ratsela; Ikechi G Okpechi
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

3.  Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study.

Authors:  Na Hao; Ben-Chung Cheng; Hong-Tao Yang; Chien-Hsing Wu; Yang-Yang Lei; Mei-Chen Chao; Pei-Ying Wang; Li-Chueh Kuo; Sin-Hua Moi; Cheng-Hong Yang; Jin-Bor Chen
Journal:  BMC Nephrol       Date:  2019-07-10       Impact factor: 2.388

4.  Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China.

Authors:  Panai Song; Dong Yang; Jine Li; Ning Zhuo; Xiao Fu; Lei Zhang; Hongqing Zhang; Hong Liu; Lin Sun; Yinghong Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.